Antibodies against actin-binding protein girdin and methods of making and using the same

a technology of actin-binding protein and antibodies, which is applied in the field of application of actin-binding protein, can solve the problems of unknown molecular mechanism by which akt promotes cell motility, and achieve the effect of affecting cell migration

Inactive Publication Date: 2016-02-11
NAGOYA UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention identifies a novel substrate of Akt, an actin-binding protein, and shows that it plays an essential role in cell motility, cell movement, and angiogenesis. The invention also provides a screening method for identifying compounds that activate or inhibit these processes using the protein or its partial peptide. The invention also describes a preventive and therapeutic medicine for disorders involving cell motility, cell movement, and angiogenesis. The technical effects of the invention include identifying a novel molecular mechanism for cell motility and promoting the development of new treatments for disorders involving cell motility, cell movement, and angiogenesis.

Problems solved by technology

However, nothing is known about molecular mechanism by which Akt promotes cell motility.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibodies against actin-binding protein girdin and methods of making and using the same
  • Antibodies against actin-binding protein girdin and methods of making and using the same
  • Antibodies against actin-binding protein girdin and methods of making and using the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

Identification of an Akt-Interacting Protein, Girdin / APE, Primary Structure Thereof and Expression Manner

[0185]To identify novel Akt substrates, a yeast two-hybrid screen using full-length human Akt1 as bait was performed, and interacting proteins using a human fetal brain cDNA library were searched for. Two independent and overlapping clones (F-10 and F-12) encoding a novel gene product were identified. When expressed in yeast, the protein encoded by the F-10 and F-12 cDNAs was shown to interact only with the carboxyl-terminal regulatory domain (RD) of Akt1. Use of 5′-rapid amplification of cDNA ends (5′-RACE) provided a clone comprising the entire coding region with an additional 3.8-kb cDNA of contiguous 5′ sequence. The full-length cDNA included an open reading frame of 5610-bp (base pair) (GenBank™ / EMBL / DDBJ accession number AB201172) and was predicted to encode a novel protein of 1870 amino acids, which was designated Girdin, with a calculated molecular mass of 220 kilodalton...

example 2

Akt Phosphorylates Girdin In Vitro and In Vivo

[0189]In vitro and in vivo assays were initially used to ascertain if Girdin and Akt physically interact with each other. Neither in vitro binding nor immunoprecipitation assays using various fragments of Girdin and Akt demonstrated the formation of a stable complex of the two proteins (data not shown), suggesting that they may normally associate in a very transient manner, as observed for the interactions between protein kinases and their substrates. It has been established that Akt preferentially phosphorylates substrates that contain the sequence R-x-R-x-x-S / T. The amino acid sequence adjacent to a serine at position 1416 (Ser-1416, RERQKS) in the CT domain of Girdin had conformed to this consensus sequence. This was the only consensus site in the protein. Since the CT domain with the putative phosphorylation site was conserved in different mammalian Girdin homologues, consideration had been given to whether Akt phosphorylates Girdin....

example 3

Girdin Associates with Actin Filaments Via its C-Terminal Domain

[0193]To determine the subcellular localization of Girdin, Vero fibroblasts were immunofluorescently stained with the anti-Girdin Ab. As shown in (a) of FIG. 3a, the results showed that Girdin was colocalized with the actin stress fibers in quiescent cells. When the cells were stimulated with EGF (50 ng / ml), they started to polarize, followed by directional extension of lamellipodia. In the EGF-stimulated cells, Girdin localized not only on the actin stress fibers but also on the lamellipodia at the leading edge, which was illustrated upon staining for the Arp2 / 3-binding protein Cortactin in (b) of FIG. 3a.

[0194]The localization of Girdin raises the possibility that Girdin is an F-actin (filamentous actin)-binding protein. To identify the actin-binding domain of Girdin, green fluorescence protein (GFP)-fused truncated versions encoding the NT (GFP-NT), N-terminal half (GFP-M1) and C-terminal half (GFP-M2) of the coiled...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Antibodies are provided that specifically bind to Acting Binding Protein Girdin (Akt Phosphorylation Enhancer), a new substrate of serine / threonine kinase. Additionally, methods of making hybridomas for producing said antibodies and methods of detecting girdin using said antibodies are provided herein. The antibodies and methods are useful for detecting girdin in tissue samples, such as tissue samples from subjects having or suspected of having a disorder in which any of cell motility, cell movement, and angiogenesis is involved.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This is a continuation of U.S. Ser. No. 12 / 085,142, which is a National Stage Entry of International Application PCT / JP2006 / 323040, filed Nov. 10, 2006, which claims priority to Japanese patent application No. 2006-060330, filed on Mar. 6, 2006 and the benefit of U.S. patent application 60 / 738,571, filed on Nov. 22, 2005, the contents of which are hereby incorporated by reference into the present application.BACKGROUND OF THE INVENTIONField of the Invention[0002]The present invention relates to an application of Actin-Binding Protein, especially, relates to an application of Acting Binding Protein Girdin (Akt Phosphorylation Enhancer), a new substrate of serine / threonine kinase, to disease associated with cell motility.[0003]Control mechanism of cell motility is closely associated with morphogenesis in generation, wound healing, and angiogenesis as well as pathological conditions such as cancer cell invasion, arteriosclerosis and immunolog...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K16/18G01N33/574
CPCG01N33/57496G01N2333/47C07K16/18A01K67/0276A01K2217/075A01K2227/105A01K2267/03C07K14/4716C12N15/113C12N15/8509C12N2310/14C12N2501/998G01N33/5029G01N2333/4703G01N2500/10A61P25/00A61P25/02A61P35/00A61P43/00A61P9/00A61P9/10
Inventor TAKAHASHI, MASAHIDEENOMOTO, ATSUSHIMUROHARA, TOYOAKI
Owner NAGOYA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap